The Improving Provider Announcement Communication Training (IMPACT) national primary care team survey aims to investigate HPV vaccine communication among a large sample of primary care team members, including physicians, physician assistants, nurse practitioners, registered nurses and medical assistants to inform future provider communication interventions.

To provide AMTAGVI per United States Prescribing Information (USPI) to patients.

The expected outcome of this proposal is a novel care pathway delivered by pharmacists to improve side effects during oral chemotherapy for patients, a known barrier to adherence, and ultimately to prevent progression and early mortality. Our long-term goal for P3OC is to develop and test new dashboard features to optimize pharmacy care and meet future needs for value-based payment models

The study purpose is to find out if (a) it's possible to deliver healthy frozen meals to homes of children receiving chemotherapy, and (b) the meals are acceptable to the children and their families.

We are implementing a digital health intervention, mPATH-Cloud, in one community health center. Patients who receive a link to the mPATH-Cloud website will be able to view a video designed to help them choose the colorectal cancer (CRC) screening test that is best for them. Patients who select colonoscopy will receive a referral from their primary care provider. Patients who do not select colonoscopy will receive a FIT in the mail. We will assess the feasibility and effectiveness of implementing mPATH-Cloud in combination with mailed FIT outreach for increasing CRC screening among community health center patients.

To discover how different forms of radiation affect the sleep, mood, and social function of adults with brain cancer. Doctors have suspected that these patients may be getting worse sleep, but no one has studied it. Since sleep is important in recovery and overall body function, understanding how radiation changes it will lead to a greater clinical understanding of the treatment.

The goal of this study is to look into the patient-reported and functional outcomes of patients who have undergone total femoral replacement or osseointegrated amputation for oncologic and traumatic indications. We want to see if functional and patient-reported outcomes are correlated and if patient satisfaction with the implants differs between surgical indications.

Some female cancers may be genetic, meaning they are passed down from a parent through DNA (our genetic code or roadmap). In people with certain types of ovarian and uterine cancer, it may be helpful to test their DNA for any errors that can cause cancer. There are lots of important pieces of information to share when someone is diagnosed with cancer, and we are exploring a new way to share information. Patients with certain types of ovarian or uterine cancers will watch a short video that explains what genetic testing is and why it is so important. They will fill out a survey about what they think about the video and if the information is helpful.

This study will evaluate the safety and tolerability of EG 70, a gene therapy, which is given inside the bladder, and its effectiveness on eliminating bladder tumors in patients with NMIBC who have failed BCG therapy and have been recommended to have their bladder removed. Giving the study drug inside the bladder is to expose cells in the lining of the bladder, including your cancerous cells, to genes that may cause an immune response inside the bladder and kill the tumor cells.

Aim 1: To co-develop the "Patient-Centered Pharmacy Pathway for Oral Chemotherapy" (P3OC) components through stakeholder engagement by conducting a modified Delphi panel with pharmacists, physicians, and other oncology healthcare providers (36,37) to determine key symptoms to assess during oral chemotherapy. Aim 2: To conduct usability testing(38,39) of the P3OC EHR Smart Form, verbal PROM, and report/dashboard with pharmacists.